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Summary 
Developmental mutations that inhibit normal formation of 
extracellular matrix (ECM) in fetal diaphragms have been identified in 
congenital diaphragmatic hernia (CDH). FRAS1-related extracellular 
matrix 1 (FREM1) plays a critical role in the development of the fetal 
diaphragm. It has been demonstrated that a deficiency of FREM1 
can lead to CDH both in humans and mice. Furthermore, FREM1-
deficient fetuses exhibit a decreased level of mesenchymal cell 
proliferation in their developing diaphragms. FRAS1 and FRAS1-
related extracellular matrix 2 (FREM2), which encode important ECM 
proteins, are secreted by mesenchymal cells during diaphragmatic 
development. The FRAS1/FREM2 gene unit has been shown to form 
a ternary complex with FREM1, which plays a crucial role during 
formation of human and rodent diaphragms. 
The first objective of this work was to investigate the 
morphological changes in the normal and abnormal diaphragm in the 
nitrofen rat model. The pleura-peritoneal folds (PPFs) in the control 
group were triangular-shaped structures protruding out from the 
lateral body wall, whereas nitrofen-exposed fetuses had an abnormal 
PPF structure, characterized by the absence of the dorsally 
projecting point of the triangular PPF. 
The second objectives was to investigate the expression 
levels and distribution of FREM1, FRAS1 and FREM2 genes and 
their proteins in the normal and abnormal diaphragm. In nitrofen-
exposed fetuses, relative mRNA expression of FREM1, FRAS1 and 
FREM2 were significantly reduced in developing diaphragms 
compared to controls. Confocal laser scanning microscopy revealed 
markedly diminished FREM1, FRAS1 and FREM2 
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immunofluorescence in diaphragmatic mesenchyme, which was 
associated with reduced proliferation of mesenchymal cells in 
nitrofen-exposed fetuses compared to controls. 
Our results suggest that decreased mesenchymal expression 
of FREM1, FRAS1 and FREM2 in the nitrofen-induced CDH model 
may cause failure of the FREM1/FRAS1/FREM2 gene complex, 
disturbing the formation of diaphragmatic ECM and thus contributing 
to the development of diaphragmatic defects in CDH. 
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1.1     Congenital diaphragmatic hernia 
1.1.1   Definition 
Congenital diaphragmatic hernia (CDH) is a congenital 
malformation characterized by the absence of the diaphragm. The 
most common type of CDH is Bochdalek hernia also known as a 
postero-lateral diaphragmatic hernia and accounts for over 95% 
cases. CDH causes intrathoracic herniation of abdominal organs and 
thus disturbing normal lung development. The size of the defect 
varies from small to very large, involving most of the hemidiaphragm. 
The most common abnormalities associated with CDH are 
cardiovascular anomalies, followed by skeletal, central nervous 
system, genitourinary, gastrointestinal, craniofacial, abdominal wall 
defects, and chromosomal and syndromic defects. Despite significant 
advances in neonatal resuscitation and intensive care, newborn 
infants with CDH continue to have high mortality. Infants with 
associated anomalies have much lower survival rates than those with 
isolated CDH. The high mortality and morbidity in CDH is mainly 
attributed to pulmonary hypoplasia and persistent pulmonary 
hypertension. 
1.1.2   Historical background 
Diaphragmatic hernia was first described in 1575 by the 
French surgeon Ambroise Pare, who reported two autopsy cases of 
traumatic diaphragmatic hernia [1]. The first description of congenital 
diaphragmatic hernia was reported by the French physician Lazarus 
Riverius as an incidental finding at post-mortem examination in a 24-
year-old man [2]. Sir Charles Holt in 1701 first reported a case of 
CDH in a child [3]. In his 1769 monograph, the Italian anatomist 
Giovanni Battista Morgagni differentiated various types of CDHs, 
including the anterior defect that bears his name [4]. Sir Astley 
Paston Cooper published in 1827 the first comprehensive report on 
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classification, symptoms and pathology of CDH [5]. In 1834, the 
French physician Rene Laennec demonstrated that the diagnosis of 
CDH could easily be made by chest auscultation and also suggested 
that laparotomy might be correct approach for hernia repair [6]. 
Henry Bowditch collected the first cohort series of patients with CDH 
in 1847 at the Massachusetts General Hospital in Boston, 
emphasizing the clinical criteria for making the diagnosis [7].  
In 1848, the Czech anatomist Vincent Alexander Bochdalek 
accurately described a posterolateral defect in the diaphragm. This 
hernia carries his name today [8]. He speculated that hernia resulted 
from an intrauterine rupture of the membrane in the lumbocostal 
triangle, but his understanding of the embryology of CDH was not 
supported by modern embryological studies.  
In 1888, the Swedish surgeon Naumann made the first 
recorded attempt at laparotomy for reduction of CDH, but was 
unsuccessful [9]. The American surgeon O’Dwyer in 1890 performed 
the first, but unsuccessful repair in a 3-year-old infant with CDH via 
an abdominal approach [10]. The German surgeon Aue reported the 
first successful repair in an adult in 1901 [11] and Heidenhain 
successfully repaired a CDH in a 9-year-old boy in 1905 [12].  
In 1925 the American surgeon Hedblom reviewed 44 CDH 
cases and showed that 75% of untreated cases with CDH died in the 
newborn period, suggesting that an earlier intervention might improve 
survival [13]. In 1929 Bettman and Hess presented the youngest 
patient with CDH, who had successfully been operated on aged 3.5 
months [14]. In the same year, Greenwald and Steiner reviewed 
symptoms of infants and children with CDH, concluding that this 
condition might not be as infrequent as it was generally believed [15]. 
Successful surgical repair of CDH were rare until 1940 when Ladd 
and Gross reported 9 of 16 patients surviving surgery, including the 
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youngest being 40 hours old [16]. In 1946 Robert Gross performed 
the first successful repair in a neonate with CDH less than 24 hours 
after birth [17]. In 1950, Koop and Johnson proposed a transthoracic 
approach as a means of closing the CDH under more direct vision 
[18]. As the surgical expertise improved further, several innovative 
techniques were introduced to address large diaphragmatic defects, 
including the use of muscle flaps and prosthetic patches [19,20].  
The first important paper describing pulmonary hypoplasia 
(PH) as the underlying pathophysiological abnormality in CDH was 
by Campanale and Rowland [21]  in 1953. Areechon and Reid [22] in 
1963 first recognized the relationship between PH and the high 
mortality in infants with CDH. In 1971, Murdock et al. [23] and Rowe 
and Uribe [24] reported that the major pathophysiological abnormality 
in CDH is persistent pulmonary hypertension (PPH). Barlett et al. [25] 
in 1976 reported the first survivors of PPH treated with extracorporeal 
membrane oxygenation (ECMO). Since then there have been a 
number of reports of use of ECMO in patients with CDH complicated 
by PPH [26]. There are many other innorvations which have been 
employed in the treatment of CDH patients who develop respiratory 
distress soon after birth and these include high frequency ventilation 
[27], delay of surgery [28] and foregoing chest tubes [29]. 
Historically, PH in CDH was believed to be the result of 
compression of the lungs by the herniating intrathoracic abdominal 
organs. However, our understanding of abnormal pulmonary 
development in relation to CDH has significantly improved because 
of data obtained in the nitrofen model of CDH. Using this model, it 
was demonstrated that pulmonary development is already affected 
prior to development of the diaphragmatic hernia, implicating that the 
lungs are primarily disturbed in their development, before mechanical 
compression can happen [30,31]. The dual-hit hypothesis, which 
explains PH in CDH as the result of 2 developmental insults, was led 
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to be postulated by this [32]. This hypothesis proposes that early 
retardation of lung development affecting both lungs occurs before 
closure of the diaphragm, probably attributed to nitrofen. The second 
insult affects only the ipsilateral lung and is the result of interference 
of fetal breathing movements of this lung caused by the herniation of 
abdominal organs into the thorax [31]. 
Although none of the surgical, transgenic, and toxicologic 
models for CDH and its associated PH and PPH have succeeded in 
completely explaining the developmental and biological basis of this 
congenital anomaly, many new insights into the pathogenesis have 
been deducted from the results of studies using these models so far.  
While the historical perspective on CDH stretching over 400 
years has seen many innovative and elegant procedures for the 
management of this condition, the mortality in CDH is still 
exceptionally high. The challenge for the future is to develop novel 
therapeutic approaches to improve the survival in neonates with the 
anomaly. 
1.1.3   Classification 
CDHs can be classified to several subtypes depending on the 
location of the defect. The most common type of CDH is a 
posterolateral Bochdalek-type (~90-95%) with the majority occurring 
on the left-sided (80%) (Figure 1): less frequently on the right-sided 
(19%) (Figure 2) or bilateral (1%) [33]. The other types are an 
anterior Morgagni-type (~2%) and a central, septum transversum-
type (very rare). Approximately 80% of the hernias are left-sided, 
19% right-sided and 1% bilateral [34]. However, close scrutiny of 
various diaphragmatic defects has demonstrated wide phenotypic 
variations in shape, size and location, suggesting that a clear 
distinction among the different types can be problematic [35]. 
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Figure 1 X-ray of the chest in a newborn showing large left-sided 
Congenital Diaphragmatic Hernia with Mediastinal shift to the right 
 
Figure 2 X-ray of the chest and upper abdomen showing large 
right-sided diaphragmatic hernia 
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1.1.4   Epidemiology 
CDH is a relatively common birth defect currently affecting 1 in 
2000 to 4000 newborns, which accounts for approximately 8% of all 
major congenital malformation, an incidence similar to cystic fibrosis 
[36,37]. Prevalence rates ranging between 2.4 and 3.8 cases per 
10,000 total births have recently been found by population-based 
studies from the USA and Western Australia [38-40]. European 
registry-based studies reported similar prevalence rates, 2.3 per 
10,000 live births [41]. However, the true incidence of CDH is 
considerably higher than seen in the neonatal surgical practice. The 
reason is because the incidence of CDH in stillborns and abortions 
seem to be less well documented [42]. Approximately one third of 
CDH infants with the associated fetal congenital anomalies can result 
in stillborn [43,44]. Therefore, hidden mortality (stillbirths, abortions) 
continues to underscore true outcomes with recent population based 
surveys reporting a persistently high mortality when all antenatal and 
perinatal cases of CDH are included [45]. 
 
1.2     Normal embryological development of the           
          diaphragm 
Formation of the primordial diaphragm is essential for normal 
diaphragmatic development. The diaphragm develops from multiple 
embryonic sources [46]. The muscle and its associated connective 
tissue and central tendon develop from three sources: the pleura-
peritoneal folds (PPFs), septum transversum and the somites [47]. 
The PPFs is a wedge-shaped structure that tapers medially from the 
lateral cervical wall to the esophageal mesentery and fuses ventrally 
with the septum transversum [48]. The PPF is of particular 
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importance in diaphragm embryogenesis, because it is the target for 
migrating diaphragmatic muscle precursor cells (MPCs) [49]. MPCs 
migrate to the PPF to form the muscular components of the 
primordial diaphragm, and then, they expand to form the fetal 
diaphragm [50]. 
 
1.3     Pathogenetical and –physiological aspects of  
          congenital diaphragmatic hernia 
The embryogenesis of the PPF has become a focus for 
elucidating the pathogenesis of CDH [48]. The PPF has been shown 
to be abnormal in the nitrofen-induced CDH rodent model, eventually 
leading to the formation of diaphragmatic defects (Figure 3) [50,51].  
Furthermore, recent evidence shows that diaphragmatic 
anomalies arise from a defect in the amuscular mesenchymal 
component, which mainly comprises of fibrous connective tissue 
[47,48]. It has been demonstrated that diaphragmatic morphogenesis 
requires the structural integrity of connective tissue, and 
developmental mutations that inhibit the formation of extracellular 
matrix (ECM) result in CDH [52,53].  
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Figure 3 Muscle precursor cells (MPCs) migrate to the PPF to 
form the muscular components of the primordial diaphragm, and then, 
they expand to form the fetal diaphragm [50].  
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1.4     Animal models of congenital diaphragmatic  
          Hernia 
Much of the current understanding of the pathophysiology of 
CDH originates from experimental animal studies. Three types of 
CDH animal models have been developed over the years: surgically 
created model, genetic model and nitrofen model [54,55]. 
1.4.1   Surgical models 
Surgical models are based on a surgical intervention making a 
diaphragmatic defect in fetal rabbits and sheep. This CDH models 
are mainly suitable to investigate interventional strategies in CDH. 
Examples of investigated interventions are administration of 
corticosteroids, in utero repair of the diaphragmatic defect and fetal 
tracheal occlusion or a combination of the two [56,57]. However, 
since this animal CDH model is surgically created during fetal life, it 
is unable to yield any insights into the embryogenesis of CDH.  
1.4.2   Genetic models 
Several mutant phenotypes (knock out model for Wt1 [46], 
Shh [58], Gli2/Gli3 [59], Slit3 [60], Fog2 [61], Gata4/Gata6 [62,63], 
COUP-TFII [64], Pdgfrα [65] and RARs [66]) have been described in 
which diaphragmatic hernia may feature but they have a range of 
often far more frequent and significant malformations that make them 
phenotypically different from human CDH. Only a mutation in FOG2 
has so far been demonstrated in a single patient with nonsyndromic 
CDH [65]. 
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1.4.3   Nitrofen model 
Toxicological studies revealed that while the herbicide nitrofen 
(2,4-dichlorophenyl-p-nitrophenyl ether) was relatively nontoxic to 
adult rats, it produced a number of developmental abnormalities of 
lung , heart, skeletal, and diaphragmatic tissues in fetuses exposed 
prenatally [67,68]. Subsequent studies demonstrated that the 
maldevelopment of the diaphragm was prominent if nitrofen was 
administered as a single dose to pregnant rats or mice between days 
8 and 11 after conception. The range and location of diaphragmatic 
defects produced by nitrofen in the perinatal rat are remarkably 
similar to those observed in the human infant with CDH. When 
nitrofen is administered to pregnant rats on gestational day 9, 
approximately 70% of the offspring show CDH and 100% of the 
offspring have pulmonary hypoplasia (PH) [69,70]. In addition, 
previous work by Migliazza et al. [71-73] has demonstrated that there 
is striking similarity in the incidence and nature of associated 
cardiovascular and skeletal defects in human CDH patients and 
nitrofen-exposed rats. Thus in view of the similarities between the 
pathologies observed in the nitrofen induced CDH rat model and 
infants with CDH, nitrofen model has been used widely as an 
experimental model to investigate the pathogenesis of CDH [70]. 
Furthermore, while there is no clear evidence suggesting that 
nitrofen-like compounds or any other enviromental factors are 
involved in the etiology of CDH in humans, an understanding of the 
mechanisms by which nitrofen is exerting its actions (e.g., affecting 
some aspects of endogenous hormone or transcription factor 
function) may lead to insights into the etiology of the disorder. During 
the past several years our research group has been investigating 
structural and molecular basis of CDH using this model [74]. 
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1.5     Malformation of the diaphragmatic mesenchyme  
The development of fetal diaphragms is a complex process, 
temporally and spatially orchestrated by multiple gene and tissue 
interactions. Normal diaphragmatic morphogenesis requires muscle 
progenitors to migrate from the somites to the developing diaphragm 
and that the muscle connective tissue forms with proper structural 
integrity [47,75]. Developmental mutations that inhibit the formation 
of ECM have been shown to result in CDH [47]. 
Copper (Cu) is an important element during diaphragm 
morphogenesis by participating in cross-linking of collagen and 
elastin fibers [52,53]. It has been reported that Cu is required for the 
activity of many enzymes that play an important role during 
development of the fetal diaphragm [76]. Cu transport is strictly 
regulated by two membrane proteins: Cu-uptake transporter 1 
(CTR1) and the Cu-efflux pump ATP7A [77]. It has been 
demonstrated that elevated CTR1 and ATP7A levels result in an 
increased intracellular Cu uptake, which upregulates the activity of 
Cu-dependent enzymes and thus contributes to crosslink of ECM 
[78]. Animals lacking Cu-dependent enzymes exhibit abnormal 
connective tissue with diaphragmatic defects [52,53]. 
Lysyl oxidase (Lox) is an extracellular Cu -dependent enzyme 
that catalyzes the cross-linking of ECM proteins [52,79]. These 
cross-links are essential for the tensile strength of collagens and the 
rubber-like properties of elastin, both abundant ECM proteins that are 
necessary for the structural integrity and function of connective tissue 
in developing diaphragms [53,80]. The expression of Lox has been 
demonstrated to be markedly increased in fibrotic tissues, including 
fetal diaphragms [53,81]. Thus, Lox appears to be critical for the 
integrity of newly developing collagen and elastic fibers by 
contributing to the structural stability of connective tissue formation 
during diaphragmatic development [47,52,53]. It has been reported 
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that lox knockout mice exhibit abnormal connective tissue with 
diaphragmatic defects [52,53]. Inactivation of the mouse lox gene 
has recently been shown to lead to perinatal death caused by 
diaphragmatic rupture [82]. This diaphragmatic rupture has been 
identified in D18.5 lox knockout mice at the site of the collagen-rich 
diaphragmatic central tendon, which allows abdominal contents to 
enter the thoracic cavity and thus disturbing formation of the 
respiratory system [52]. These findings in the lox knockout mice 
strongly suggest that a reduction in Lox activity may have a critical 
effect on the pathogenesis of CDH [52,53].  
We recently demonstrated that diaphragmatic expression of 
Lox is decreased in the nitrofen-induced CDH model [83].  In addition, 
we also recently reported that the Lox deficiency and our findings of 
decreased expression CTR1 and ATP7A in the developing 
diaphragm indicate that the loss of connective tissue integrity may be 
a cause of CDH [84].  Disruption of the Cu-deficient signalling 
pathway may impair cross-linking of elastin and collagen which is 
essential for the proper structural integrity of connective tissue and its 
tensile strength. 
The origin of CDH is assumed to lie in a malformation of the 
amuscular primordial diaphragm [75]. It is known that fetal 
diaphragmatic development requires the structural integrity of its 
underlying mesenchymal tissue [47]. Developmental mutations that 
inhibit the formation of normal diaphragmatic mesenchyme have 
been shown to cause CDH [47,75]. Kinesin family member 7 (Kif7), 
an essential component of the Sonic hedgehog (Shh) signaling 
cascade, has recently been identified to play a crucial role in 
diaphragmatic development by controlling the proliferation of 
mesenchymal cells [85-87].  In addition, the loss of Kif7 has been 
reported to result in diaphragmatic defects [85]. Furthermore, it has 
been demonstrated that the diaphragmatic expression of Kif7 was 
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decreased in the nitrofen-induced CDH model, thus suggesting that 
decreased Kif7 expression during diaphragmatic development may 
interfere with mesenchymal cell proliferation, leading to defective 
PPFs, and resulting in diaphragmatic defects in this model [88]. 
FRAS1-related extracellular matrix 1 (FREM1) encodes an 
extracellular matrix protein. Recently a case of a female child with an 
isolated left-sided posterolateral CDH was reported that carried a 
FREM1 deletion [89,90]. In addition, it has been reported that 
FREM1 is expressed in the anterior portion of the developing 
diaphragm and that FREM1 deficiency causes anterior CDH in mice 
[89,91]. Moreover, FREM1-deficient fetuses exhibit a decreased level 
of mesenchymal cell proliferation in their developing diaphragms [89]. 
These results confirm that FREM1 plays a critical role in the 
development of the fetal diaphragm and that FREM1 deficiency can 
cause CDH in both humans and mice. Moreover, FREM1 is known to 
form a ternary complex in the basement membrane with FRAS1 and 
FRAS1-related extracellular matrix 2 (FREM2) (Figure 4) [92]. 
Recently, FRAS1 and FREM2 gene have been identified as the 
causative genes in human Fraser syndrome which is infrequently 
associated with CDH [93,94]. FRAS1 and FREM2 also encode 
essential ECM proteins, which are both expressed in the fetal 
diaphragm [89]. Although CDH has not yet been reported in FRAS1- 
or FREM2-deficient mice, failure to form a FREM1/FRAS1/FREM2 
complex may predispose to the development of diaphragmatic 
defects. 
25 
 
 
Figure 4 A model for the reciprocal stabilization of the Fras1, 
Frem2, and Frem1 through complex formation at the epidermal 
basement membrane [92]. 
 
1.6     Aims and objectives 
In this project we aimed to investigate the molecular 
mechanism underlying the development of CDH by examining the 
expression of key candidate genes at a critical time in the 
development of diaphragm. 
The first objective of this work was to investigate the 
morphological changes in the normal and abnormal diaphragm in the 
nitrofen rat model. 
The second objectives was to investigate the expression 
levels and distribution of candidate genes and proteins associated 
with CDH (i.e. FREM1, FRAS1 and FREM2) in the normal and 
abnormal diaphragm. 
 
26 
 
 
 
 
 
 
 
 
 
Chapter 2 
 
- 
 
Material and Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
27 
 
2.1     Animal model and experimental design 
2.1.1   Animal protocol 
After obtaining ethical approval (Ref. REC668b) from the local 
research ethics committee, pathogen-free adult Sprague-Dawley® 
rats (Harlan Laboratories, Shardlow, UK) were kept in a well-
controlled environment (50-55% humidity, 19-21℃, 12-h light period, 
food and water ad libitum), and males and females were mated 
overnight. Day 0 of Pregnancy will be taken as the day on which a 
vaginal plug was found and confirmed by the presence of 
spermatozoa in a vaginal swab. On day 9 of gestation, the rat was 
carefully restrained with its neck extended, and a stainless steel 
straight cannulae (75mm x 16G) was passed gently down the 
esophagus to the stomach and 100mg of Nitrofen (2,4-
dichlorophenyl-p-nitrophenylether, WAKO Chemicals GmbH, Neuss, 
Germany) dissolved in 1 ml of olive oil was administered. This dose 
of Nitrofen has been established to give the highest proportion of 
embryos in a litter with CDH. After this procedure, although no 
adverse effects had been described on the dam rat after gastric 
administration of Nitrofen, the rat was closely monitored twice daily 
for signs of distress. Each rat in the control group received equivalent 
volume of olive oil without nitrofen via the same route and technique.  
Nitrofen is the common name of the compound 2,4-
dichlorophenyl-p-nitrophenyl ether (International Chemical safety 
Cards #0929) that was previously used as a contact herbicide agent. 
Field handlers of the herbicide were subject to inhalation and dermal 
contact exposure during application procedures, causing irritation to 
the respiratory tract and dermatitis. For these reasons Nitrofen is no 
longer used as an herbicide. No short-term adverse effects have 
been described if intragastrically given to a rat; however, it is highly 
teratogenic if given to a pregnant rat and this is the effect we are 
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expecting to achieve in this research. Nitrofen was stored well closed, 
separated from food and properly labelled. Protective clothes, gloves 
and face mask was used when handling Nitrofen avoiding all contact 
or spilling. 
Harvesting of Study fetuses was carried out under terminal 
anaesthesia. On gestational day 13, 15 and 18 each rat from the 
control and experimental group was carefully restrained and 
anaesthesia was induced with Isoflurane 2% in order to sedate it. 
After that, an intracardiac injection of Pentobarbitol Sodium 100mg 
was given in order to humanely kill the dam and its foetuses. 
Following, under aseptic conditions, the embryos were recovered by 
caesarean section with microsurgical technique and fixed according 
to each limb of the study. 
The Department of Health and Children approved the protocol 
of these animal experiments (ref. B100/4378) under the Cruelty to 
Animals Act, 1876; as amended by European Communities 
Regulations 2002 and 2005. 
2.1.2   Preparation for diaphragm samples 
Fetuses were harvested by cesarean section on selected time-points 
D13, D15 and D18 and were inspected for diaphragmatic defects 
(Figure 5). All diaphragmatic samples (n=72) were dissected under a 
stereomicroscope (Leica Microsystems AG, Heerbrugg, Switzerland) 
and divided in control and nitrofen-exposed specimens (n=12 per 
time-point and experimental group).  Samples were either stored in 
TRIzol® reagent (Invitrogen, Carlsbad, USA) for subsequent RNA 
isolation, or fixed in 10% paraformaldehyde (PFA) (Santa Cruz 
Biotechnology Inc, Heidelberg, Germany) for histologic processing. 
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Figure 5 Experimental design 
 
 
2.2     Total RNA isolation and complementary DNA   
          synthesis 
In order to obtain total RNA from PPFs from D13 fetuses and 
developing diaphragms from D15 fetuses, paraffin-embedded whole 
animals were transversely sectioned at a thickness of 10 µm and 
mounted on PEN membrane glass slides® (MDS Analytical 
Technologies, Sunnyvale, USA).  After deparaffinization, rehydration, 
hematoxylin staining, and dehydration, primordial diaphragms were 
dissected by laser capture microdissection (Arcturus XT® Instrument, 
MDS Analytical Technologies, Sunnyvale, USA).  Total RNA was 
extracted using a High Pure FFPE RNA Micro Kit® (Roche 
Diagnostics, West Sussex, UK) according to the manufacturer’s 
protocol.  Total RNA from fetal diaphragm (D18) samples were 
extracted with the acid guanidinium thiocyanate-phenol-chloroform 
extraction method using a TRIzol® reagent (Invitrogen, Carlsbad, 
USA) according to the manufacturer’s protocol. Total RNA 
quantification was performed spectrophotometrically (NanoDrop ND-
1000 UV-Vis® Spectrophotometer, Wilmington, USA), and RNA 
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solution was stored at -20°C.  Synthesis of cDNA was performed 
using a Transcript High Fidelity cDNA Synthesis Kit® (Roche 
Diagnostics, Grenzach-Whylen, Germany) according to the 
manufacturer’s protocol.  All cDNA samples were stored at 4°C until 
further use. 
 
2.3     Quantitative real-time polymerase chain reaction 
Quantitative real-time polymerase chain reaction was 
performed using a LightCycler® 480 SYBR Green I Master Mix 
(Roche Diagnostics, Mannheim, Germany) according to the 
manufacturer’s protocol.  Gene-specific primer pairs used in this 
study are listed in Table 1.  After an initialization phase at 95°C for 5 
min, 55 amplification cycles were carried out.  Each cycle included an 
initial denaturation step at 95°C for 10 sec, an annealing step at 60°C 
for 15 sec and an elongation step at 72°C for 10 sec.  The final 
elongate temperature was 65°C for 1 min.  Relative mRNA 
expression levels of FREM1, FRAS1 and FREM2 were measured 
with a Light Cycler® 480 instrument (Roche Diagnostics, West 
Sussex, UK) and gene levels were normalized to the housekeeping 
gene β-actin.  All experiments were run duplicated for each sample 
and primer pair. 
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Table 1 Primer sequences for quantitative real-time polymerase 
chain reaction 
Gene Sequence (5ۥ-3ۥ) Product size 
(bp) 
FREM1 
   Forward 
   Reverse 
 
CAC AGC AGC CAT CAC AAG TT 
AGC ATG GAC CCT TGG ATC AA 
 
125 
FRAS1 
   Forward 
   Reverse 
FREM2 
   Forward 
   Reverse 
β-actin 
   Forward 
   Reverse 
 
GCT TCA GAA ACC TCC ACA GC 
TCA GGC CAT CTG TGA CTG AG 
 
ACC CAG GAT GAA GTG GAC AG 
GGA CAC GCC CTT ACT TAC CA 
 
TTG CTG ACA GGA TGC AGA AG 
TAG AGC CAC CAA TCC ACA CA 
 
179 
 
 
180 
 
 
108 
 
 
 
2.4     Histological examination, immunofluorescence  
          staining and confocal laser scanning microscopy 
Following fixation in 10% PFA, whole D13 and D15 fetuses as 
well as D18 trunks were paraffin-embedded, transversely sectioned 
at a thickness of 5 µm, and mounted on polylysine-coated slides 
(VWR International, Leuven, Belgium). Resulting tissue sections 
were deparaffinized with xylene and rehydrated through ethanol and 
distilled water. Conventional hematoxylin- and eosin-staining (Sigma 
Aldrich, Saint Louis, USA) was used to investigate the diaphragmatic 
histology. 
All sections for immunofluorescence staining were incubated 
with phosphate-buffered saline (PBS) containing 1.0% Triton X-100 
(Sigma Aldrich Ltd, Arklow, Ireland) for 20 min at room temperature 
to improve cell permeabilization. Sections were then washed in PBS 
+ 0.05% Tween (Sigma Aldrich, Saint Louis, USA) and subsequently 
blocked with 3 % bovine serum albumin (Sigma Aldrich, Saint Louis, 
USA) for 30 min to avoid non-specific absorption of immunoglobulin. 
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The blocking solution was rinsed off and sections were incubated 
with affinity-purified primary antibodies either against FREM1 (rabbit 
polyclonal, sc-98447; 1:100), FRAS1 (goat polyclonal, sc-79244, 
1:100), FREM2 (mouse polyclonal, sc-376555, 1:100) and GATA4 
(rabbit polyclonal, sc-9053; 1:100) (Santa Cruz Biotechnology Inc, 
Heidelberg, Germany) overnight at 4 °C. On the next day, sections 
washed in PBS + 0.05% Tween and incubated with corresponding 
secondary antibodies (donkey anti-rabbit Alexa 647-A150067, 1:250, 
donkey anti-goat Alexa 555-A21432, 1:250 and donkey anti-mouse 
Alexa 488-A150109, 1:250) (Abcam plc, Cambridge, UK) for 1 h at 
room temperature. After another washing step in PBS + 0.05% 
Tween, sections were counterstained with a DAPI antibody 
(10236276001, 1:1,000) (Roche Diagnostics GmbH, Mannheim, 
Germany) for 10 min, washed again, and mounted with glass 
coverslips using Sigma Mounting Medium (Sigma-Aldrich, St. Louis, 
MO, USA).  
All sections were scanned with a ZEISS LSM 700 confocal 
microscope (Carl Zeiss MicroImaging GmbH, Jena, Germany) and 
independently evaluated by two investigators. 
 
2.5     Statistical analysis  
All numerical data are presented as means ± standard error of 
the mean.  Differences between two groups were tested using an 
unpaired Student’s t test when the data had normal distribution or a 
Mann-Whitney U test when the data deviated from normal distribution. 
Statistical significance was accepted at P values of less than 0.05. 
 
 
 
 
 
33 
 
 
 
 
 
 
 
 
 
Chapter 3 
 
- 
 
Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
34 
 
3.1     The morphological changes in the normal and 
          abnormal PPF in the nitrofen rat model 
The PPF in controls was triangular-shaped structures 
protruding out from the lateral body wall (Figure 6).  Consistent with 
previous reports, nitrofen-exposed fetuses had an abnormal PPF 
structure, characterized by the absence of the dorsally projecting 
point of the triangular PPF (Figure 7). 
 
 
Figure 6 Hematoxylin- and eosin-staining in developing fetal 
diaphragms on D13. PPFs in the control group were triangular-
shaped structures protruding out from the lateral body wall. 
 
Figure 7 Hematoxylin- and eosin-staining in developing fetal 
diaphragms on D13. Nitrofen-exposed fetuses had an abnormal PPF 
structure, characterized by the absence of the dorsally projecting 
point (asterisk). 
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3.2     Relative mRNA expression of FREM1, FRAS1 and  
          FREM2 in rat PPFs and fetal diaphragms 
Relative mRNA expression of FREM1 was significantly 
reduced in PPFs of nitrofen-exposed fetuses on D13 (0.30±0.23 vs. 
0.83±0.19; p<0.05), developing diaphragms of nitrofen-exposed 
fetuses on D15 (0.54±0.22 vs. 1.19±0.28; p<0.05) and fully 
muscularized diaphragms of nitrofen-exposed fetuses on D18 
(0.49±0.37 vs. 0.97±0.53; p<0.05) in comparison with controls 
(Figure 8). 
In addition, relative mRNA expression of FRAS1 (Figure 9) 
and FREM2 (Figure 10) were significantly reduced in PPFs of 
nitrofen-exposed fetuses on D13 (1.76±0.86 vs. 3.09±1.15; p<0.05 
and 0.47±0.26 vs. 0.82±0.36; p<0.05), developing diaphragms of 
nitrofen-exposed fetuses on D15 (1.45±0.80 vs. 2.63±0.84; p<0.05 
and 0.41±0.16 vs. 1.02±0.49; p<0.05) and fully muscularized 
diaphragms of CDH fetuses on D18 (1.35±0.75 vs. 2.32±0.92; 
p<0.05 and 0.37±0.24 vs. 0.70±0.32; p<0.05) compared to controls. 
 
Figure 8 FREM1 expression in pleuroperitoneal folds (PPFs), developing diaphragms and 
fully muscularized diaphragms. Gene levels were normalized to the housekeeping gene β-actin. (12 
samples per time point and per treatment) 
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Figure 9 FRAS1 expression in pleuroperitoneal folds (PPFs), developing diaphragms and 
fully muscularized diaphragms. Gene levels were normalized to the housekeeping gene β-actin. (12 
samples per time point and per treatment) 
 
 
Figure 10 FREM2 expression in pleuroperitoneal folds (PPFs), developing diaphragms and 
fully muscularized diaphragms. Gene levels were normalized to the housekeeping gene β-actin. (12 
samples per time point and per treatment) 
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3.2     Immunofluorescence of FREM1 and GATA4 in 
          fetal rat diaphragms 
Immunofluorescence staining for FREM1 was performed to 
evaluate whether the decreased amount of FREM1 transcripts were 
also reflected in a decreased amount of FREM1 proteins. 
Immunofluorescence staining for FREM1 was further combined with 
the mesenchymal marker GATA4 in order to localize FREM1 protein 
expression and tissue distribution in developing fetal diaphragms. 
Confocal laser scanning microscopy revealed a strong diaphragmatic 
FREM1 immunofluorescence in control fetuses on D13, D15 and D18, 
which was co-localized with GATA4 immunofluorescence.  However, 
the diaphragmatic FREM1 immunofluorescence was markedly 
diminished in nitrofen-exposed fetuses on D13, D15 and D18 
compared to controls, which was associated with a reduced 
proliferation of diaphragmatic mesenchymal cells (Figure 11). 
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Figure 11 Hematoxylin- and eosin-staining in developing fetal diaphragms on D13, D15 and 
D18 (left column of each time-point and experimental group). FREM1 (red staining) and GATA4 
immunofluorescence (green staining) with DAPI (blue staining) in developing fetal diaphragms on D13, 
D15 and D18: Control fetuses showed a strong FREM1, which was co-localized with the mesenchymal 
marker GATA4. Nitrofen-exposed fetuses exhibited a markedly diminished FREM1 immunofluorescence, 
which was associated with a reduced proliferation of diaphragmatic mesenchymal cells. (12 samples 
per time point and per treatment) 
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3.3     Immunofluorescence evaluation of FRAS1,  
          FREM2 and GATA4 in rat PPFs and fetal  
          diaphragms 
Immunofluorescence staining for FRAS1 and FREM2 was 
combined with the mesenchymal marker GATA4 in order to evaluate 
FRAS1 and FREM2 protein expression and localization in PPFs and 
fetal diaphragmatic tissue on D13, D15 and D18. Confocal laser 
scanning microscopy revealed a co-expression of FRAS1 and 
FREM2 with GATA4, and confirmed the qRT-PCR results by showing 
a markedly diminished FRAS1 (Fig. 12) and FREM2 (Fig. 13) 
immunofluorescence in the diaphragmatic mesenchyme of nitrofen-
exposed PPFs and CDH fetuses on D13, D15 and D18 compared to 
controls. This finding was associated with a reduced proliferation of 
mesenchymal cells in nitrofen-exposed PPFs and fetal CDH 
diaphragms on D13, D15 and D18 compared to controls. 
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Figure 12 Immunofluorescence evaluation of PPFs and fetal diaphragms for FRAS1 (red 
staining) and GATA4 (green staining) with DAPI (blue staining). Confocal laser scanning microscopy 
showed co-expression of FRAS1 and GATA4 primarily in diaphragmatic mesenchymal cells and 
revealed strikingly diminished FRAS1 immunofluorescence in PPFs (D13), developing diaphragms 
(D15) and fully muscularized diaphragms (D18) of nitrofen-exposed CDH fetuses compared to controls. 
(12 samples per time point and per treatment) 
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Figure 13 Immunofluorescence evaluation of PPFs and fetal diaphragms for FREM2 (red 
staining) and GATA4 (green staining) with DAPI (blue staining). Confocal laser scanning microscopy 
demonstrated co-localization of FREM2 and GATA4 mainly in diaphragmatic mesenchymal cells and 
further showed a markedly diminished FREM2 immunofluorescence in PPFs (D13), developing 
diaphragms (D15) and fully muscularized diaphragms (D18) of nitrofen-exposed CDH fetuses compared 
to controls. (12 samples per time point and per treatment) 
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4.1     Discussion 
Given the frequency with which CDH occurs, an 
understanding of the genetic, cellular and morphogenetic 
mechanisms regulating diaphragm development, both normally and 
during herniation, is critical.  Many fundamental questions about 
diaphragm development remain unanswered.  The morphogenesis of 
the diaphragm’s muscle connective tissue and their relationship to 
the transverse septum and PPF remain poorly understood. 
Amuscular mesenchymal component of the PPF is defective 
and does not provide a complete foundation for the formation of 
diaphragmatic musculature [47,75]. Although the pathogenesis of 
diaphragmatic defects has been extensively studied, the molecular 
basis of the abnormal ECM formation in CDH remains unclear. 
Investigating the expression levels and distribution of candidate 
genes and proteins involved in ECM formation in CDH in the normal 
and abnormal diaphragm in the early gestation should provide new 
insights into the pathogenesis of CDH. 
We recently reported that the diaphragmatic expression of 
Copper (Cu)-dependent enzymes lysyl oxidase, Cu-uptake 
transporter 1 and Cu-efflux pump ATP7A were decreased in the 
nitrofen-induced CDH model [83,84]. These results indicated that 
disruption of the Cu-deficient signalling pathway may impair cross-
linking of elastin and collagen, which is essential for the proper 
structural integrity of the diaphragmatic mesenchymal tissue. 
Furthermore, it has been demonstrated that the diaphragmatic 
expression of an essential component of the Sonic hedgehog 
signalling cascade, kinesin family member 7 (Kif7) was decreased in 
the nitrofen-induced CDH model, thus suggesting that decreased 
Kif7 expression during diaphragmatic development may interfere with 
mesenchymal cell proliferation, leading to defective PPFs, and 
resulting in diaphragmatic defects in this model [88]. 
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FREM1 encodes an extracellular matrix protein. Recently a 
case of a female child with an isolated left-sided posterolateral CDH 
was reported that carried a FREM1 deletion [89,90]. In addition, it 
has been reported that FREM1 is expressed in the anterior portion of 
the developing diaphragm and that FREM1 deficiency causes 
anterior CDH in mice [89,91]. Moreover, FREM1-deficient fetuses 
exhibit a decreased level of mesenchymal cell proliferation in their 
developing diaphragms [89]. These results confirm that FREM1 plays 
a critical role in the development of the fetal diaphragm and that 
FREM1 deficiency can cause CDH in both humans and mice. 
Moreover, FREM1 is known to form a ternary complex in the 
basement membrane with FRAS1 and FREM2 [92]. Recently, 
FRAS1 and FREM2 gene have been identified as the causative 
genes in human Fraser syndrome which is infrequently associated 
with CDH [93,94]. FRAS1 and FREM2 also encode essential ECM 
proteins, which are both expressed in the fetal diaphragm [89]. 
Although CDH has not yet been reported in FRAS1- or FREM2-
deficient mice, failure to form a FREM1/FRAS1/FREM2 complex may 
predispose to the development of diaphragmatic defects. 
In the present study, we demonstrated for the first time that 
the diaphragmatic FREM1, FRAS1 and FREM2 gene expression is 
significantly reduced in PPFs on D13, developing diaphragms on 
D15 and fully muscularized diaphragms on D18 in the nitrofen-
induced CDH model compared to control littermates. Additionally, 
immunofluorescence staining for FREM1, FRAS1 and FREM2 
showed a co-localization with GATA4, which is a crucial transcription 
factor during diaphragmatic development and strongly expressed by 
mesenchymal cells in developing fetal diaphragms [62,95]. Confocal 
laser scanning microscopy revealed a markedly diminished FREM1, 
FRAS1 and FREM2 expression in the diaphragmatic mesenchyme of 
nitrofen-exposed PPFs and CDH fetuses on D13, D15 and D18 
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compared to controls. Hence, these results confirmed that the 
quantitative decrease in diaphragmatic FREM1, FRAS1 and FREM2 
mRNA transcripts were also translated to the protein level. A 
previous study from our laboratory has provided strong evidence that 
the diaphragmatic expression of GATA4 is downregulated in the 
nitrofen model, suggesting that a decreased GATA4 expression may 
impair the diaphragmatic development in nitrofen-induced CDH [96]. 
In addition, it has recently been demonstrated that FREM1 and 
GATA4 interact genetically in the development of lung lobulation 
defects [97]. Besides the markedly diminished FREM1, FRAS1 and 
FREM2 expression in nitrofen-exposed PPFs and fetal diaphragms 
with CDH, we also found a reduced proliferation of mesenchymal 
cells in nitrofen-exposed PPFs and fetal CDH diaphragms on D13, 
D15 and D18, which indicates a disrupted formation of its underlying 
ECM. 
 
4.2     Future directions 
Newborns born with CDH hernia are at high risk of mortality 
and significant long-term morbidity. The nitrofen rat model has 
proved to be a good model for studying this malformation and its 
pathogenesis. This research will help determining the potential 
mechanism that leads to the development of diaphragmatic defect in 
CDH. 
Further studies on connective tissue formation and the 
structural integrity of the developing diaphragm are required and 
should provide new insights into the pathogenesis underlying 
diaphragmatic defects in CDH. 
As with other congenital anomalies, an improved 
understanding of the pathogenesis of CDH may help to design new 
treatment modalities targeted at specific developmental insults. 
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Ultimately, the goal is to positively modulate the natural course of the 
disease and maybe even help to prevent it from happening at all. 
 
4.3     Conclusions 
Our results suggest that decreased mesenchymal expression 
of FREM1, FRAS1 and FREM2 in the nitrofen-induced CDH model 
may cause failure of the FREM1/FRAS1/FREM2 gene complex unit, 
disturbing the formation of diaphragmatic ECM and thus contributing 
to the development of diaphragmatic defects in CDH. These findings 
may therefore provide new insights into the pathomechanisms 
underlying CDH. 
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